Cardiovascular issues in people with type 2 diabetes are approximately twice as common as in individuals without type 2. The results of a large trial, REWIND, suggest that dulaglutide (also called Trulicity) has cardioprotective properties. Read more
A small trial found that an endoscopic therapeutic procedure, which involved putting a small balloon filled with hot water down the patient’s throat, successfully reduced the need for insulin use in most participants. The procedure burns away some of the small intestine’s surface cells which are then replaced; the new cells signal the body to […]
Researchers examining the effects of combining the diabetes drugs canagliflozin, an SGLT2i, plus liraglutide, a GLP-1 RA, found that the combo was not much more effective than for lowering HBA1c than liraglutide alone, but the combo did have some weight loss benefits. Read more
Researchers say they may have found a “remote control” for managing diabetes. The researchers found that exposing diabetic mice to a combination of static electric and magnetic fields for a few hours per day reduced their blood sugar and normalized their bodies’ responses to insulin. Read more
The SGLT-2 inhibitors are a relatively new treatment for type 2 diabetes, and the authors of this study felt their use had not yet been adequately studied in the elderly. They examined the effect of one SGLT-2 inhibitor, dapagliflozin (brand name Farxiga) to assess its effects on blood glucose control and kidney health in senior […]
Daily consumption of both green tea and coffee is linked to a lower risk of dying in people with type 2 diabetes, according to research published in the online journal BMJ Open Diabetes Research & Care. The researchers found that drinking 4 or more cups of green tea, plus 2 or more cups of coffee, […]
Selective Serotonin Reuptake Inhibitors (SSRIs) are a type of antidepressants often used to treat children and teenagers. While one study found an increased risk of type 2 diabetes in Medicaid-insured children prescribed SSRIs (possibly due to weight gain associated with SSRIs), a new study says the risk may not be as great as was thought. […]
A study based in London, U.K., found that adults of South Asian and African Caribbean ethnicity are more likely to be diagnosed with early-onset type 2 diabetes than white adults. Physicians should be aware of the elevated risk and focus on management and prevention of type 2 risk in young adults of these ethnicities, the […]
Weight loss is frequently recommended for people who are newly diagnosed with type 2 diabetes, but weight loss after new-onset diabetes may increase risk for pancreatic cancer, researchers say. The researchers suggest screening for pancreatic cancer in patients with diabetes and weight loss. Read more
A recent study assessed loneliness by asking more than 4,000 adults without type 2 diabetes how often they felt isolated or lacking companionship. Participants were followed up for about 10 years to see how many developed diabetes. By the end of the study, loneliness was associated with 46 percent greater odds of developing type 2 […]
People with type 2 diabetes are known to have problems with cardiovascular exercises; their reduced peak of VO2 (the maximum rate of oxygen consumption measured during incremental exercise) is linked to the development of cardiovascular diseases. A recent study sought a better understanding of the link between cardiovascular dysfunction and type 2 diabetes. Read more
Researchers have found that going to bed early may be beneficial for people with type 2 diabetes. People with type 2 who were night owls, staying up late and rising later in the morning, were less likely to get adequate exercise than those who maintained earlier bedtimes, researchers say. Read more
Researchers are finding a two-way relationship between COVID-19 and diabetes: people with diabetes are at increased risk of severe complications from COVID-19, and people who contract COVID-19 are at an increased risk of new-onset diabetes. An international research project, the CoviDIAB Registry project, will seek to understand why. Read more
Diabetes is a well known risk factor for heart disease, and cardiac issues are a major cause of death among people with diabetes. Researchers say they have found that exercise causes the release of small sequences of genetic code in the heart, called microRNA, which increase protein production to improve heart structure and function. Read […]
Heart Rate Variability (HRV) is the variation between two consecutive heartbeats. Previous research has suggested HRV abnormalities, such as a significant reduction in HRV, may precede the development of cardiovascular disease or diabetes. Researchers conducted a study to see if HRV alone could predict diabetes risk. Read more
While most of us are familiar with type 1 and type 2 diabetes, there are other, rarer forms of the disease, that are poorly understood. A new initiative from the National Institutes of Health (NIH), The Rare and Atypical Diabetes Network (RADIANT) plans to screen about 2,000 people who have unknown or atypical forms of […]
For most people diagnosed with type 2 diabetes, the first treatments to be prescribed (aside from lifestyle changes like diet and exercise) are metformin or sulfonylureas. If these do not achieve the desired result, doctors may add additional medications. New research says that there is reason to add the SGLT-2 inhibitor early, as the second […]
People whose mothers had diabetes during pregnancy are at increased risk for early heart disease as young adults. The researchers say that the risk applies to both children of mothers who have pre-existing type 2 diabetes when they become pregnant, and children whose mothers developed gestational diabetes during their pregnancies. Read more
Diabetes-related cardiovascular diseases can be prevented by relatively simple and affordable steps, researchers say, including improved communication between healthcare providers and patients, improved early detection, and better control of factors like blood glucose, cholesterol, and blood pressure. Read more
Proton pump inhibitors, or PPIs, are a class of drugs used to treat acid reflux, peptic ulcers and indigestion. Researchers have found regular use of these drugs is linked to an increased risk of developing type 2 diabetes, and the risk increases the longer the drugs are taken. Read more